pentetic acid has been researched along with Neuroendocrine Tumors in 79 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirteen (13) patients with liver neuroendocrine carcinomas metastases, positive for somatostatin receptors, confirmed by scintigraphy were infused with 4070-7030 MBq per session of In-111-octreotide after selective hepatic catheterization, exploiting the catastrophic activity of Indium Auger and Internal Conversion electron emission on cell DNA." | 3.73 | Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings. ( Dimitriou, P; Dimitropoulos, N; Hatzioannou, A; Kontogeorgakos, D; Koutoulidis, V; Limouris, GS; Lyra, M; Mourikis, D; Papanikolos, G; Stravaka, A; Vlahos, L, 2005) |
| " Maximal potassium levels were within the toxic range (6." | 2.71 | Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. ( de Jong, M; Kooij, PP; Krenning, EP; Rolleman, EJ; Valkema, R, 2003) |
| "In patients with midgut carcinoids, (all scintigraphy positive), false Rin situ recordings were found in 4/29 macroscopically identified tumours." | 2.68 | Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. ( Ahlman, H; Fjalling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wangberg, B, 1996) |
| "Neuroendocrine differentiation of prostate cancer (PCa) is a relatively frequent event, generally understudied, that carries important prognostic information." | 2.55 | Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer. ( Ciarmiello, A; Giovacchini, G; Giovannini, E; Riondato, M, 2017) |
| "The value of SRI in patients with other tumors, such as breast cancer or malignant lymphomas, or in patients with granulomatous diseases has to be established." | 2.41 | Peptide receptor imaging and therapy. ( de Jong, M; Krenning, EP; Kwekkeboom, D, 2000) |
| "There are indications that breast carcinomas, of which some express the somatostatin receptor (SS-R), can be divided this way." | 2.40 | Somatostatin receptors and breast cancer. ( Krenning, EP; Kwekkeboom, DJ; van Eijck, CH, 1998) |
| "Of the 60 evaluable patients, 51 had carcinoid tumours, 3 gastrinomas, 2 glucagonomas, 1 insulinoma and 3 paragangliomas." | 1.33 | Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours. ( Arnold, R; Bauhofer, A; Béhé, MP; Behr, TM; Gotthardt, M; Grass, J; Kalinowski, M; Oyen, WJ; Rinke, A; Schipper, ML, 2006) |
| "For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500." | 1.29 | Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. ( Ahlman, H; Fjälling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wängberg, B, 1995) |
| "In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
| "18 patients with metastatic carcinoids who underwent 111In-pentetreotide scanning were all somatostatin receptor positive." | 1.29 | Somatostatin receptor imaging: predictive and prognostic considerations. ( Anthony, LB; Delbeke, D; Martin, W; Sandler, M, 1996) |
| "In midgut carcinoid (MC) patients (all scintigraphy positive), 4/29 macroscopically identified tumours gave false R(in situ)." | 1.29 | Radioisotope-guided surgery in patients with neuroendocrine tumours. ( Ahlman, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 30 (37.97) | 18.2507 |
| 2000's | 28 (35.44) | 29.6817 |
| 2010's | 21 (26.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, S | 1 |
| Kobayashi, N | 1 |
| Tokuhisa, M | 1 |
| Goto, A | 1 |
| Takano, S | 1 |
| Takada, Y | 1 |
| Kaneta, T | 1 |
| Mori, R | 1 |
| Matsuyama, R | 1 |
| Endo, I | 1 |
| Yamanaka, S | 1 |
| Nakajima, A | 1 |
| Inoue, T | 1 |
| Ichikawa, Y | 1 |
| Cuccurullo, V | 2 |
| Di Stasio, GD | 1 |
| Mansi, L | 2 |
| Bol, K | 1 |
| Haeck, JC | 1 |
| Groen, HC | 1 |
| Niessen, WJ | 1 |
| Bernsen, MR | 1 |
| de Jong, M | 11 |
| Veenland, JF | 1 |
| Pool, SE | 1 |
| Kam, BL | 2 |
| Koning, GA | 1 |
| Konijnenberg, M | 2 |
| Ten Hagen, TL | 1 |
| Breeman, WA | 8 |
| Krenning, EP | 17 |
| van Eijck, CH | 5 |
| Pfeifer, A | 1 |
| Knigge, U | 1 |
| Binderup, T | 1 |
| Mortensen, J | 1 |
| Oturai, P | 1 |
| Loft, A | 1 |
| Berthelsen, AK | 1 |
| Langer, SW | 1 |
| Rasmussen, P | 1 |
| Elema, D | 1 |
| von Benzon, E | 1 |
| Højgaard, L | 1 |
| Kjaer, A | 1 |
| Limouris, GS | 2 |
| Poulantzas, V | 1 |
| Trompoukis, N | 1 |
| Karfis, I | 1 |
| Chondrogiannis, S | 1 |
| Triantafyllou, N | 1 |
| Gennimata, V | 1 |
| Moulopoulou, LE | 1 |
| Patsouris, E | 1 |
| Nikou, G | 1 |
| Michalaki, V | 1 |
| Fragulidis, G | 1 |
| Paphiti, M | 1 |
| McCready, RV | 1 |
| Colletti, PM | 1 |
| Cook, GJ | 1 |
| Rubello, D | 1 |
| Deppen, SA | 1 |
| Blume, J | 1 |
| Bobbey, AJ | 1 |
| Shah, C | 1 |
| Graham, MM | 1 |
| Lee, P | 1 |
| Delbeke, D | 2 |
| Walker, RC | 1 |
| Brabander, T | 1 |
| Teunissen, J | 1 |
| Kwekkeboom, D | 2 |
| Giovacchini, G | 1 |
| Giovannini, E | 1 |
| Riondato, M | 1 |
| Ciarmiello, A | 1 |
| Castaldi, P | 1 |
| Rufini, V | 1 |
| Treglia, G | 1 |
| Bruno, I | 1 |
| Perotti, G | 1 |
| Stifano, G | 1 |
| Barbaro, B | 1 |
| Giordano, A | 1 |
| Busse, F | 1 |
| Führer, D | 1 |
| Stumvoll, M | 1 |
| Schneider, JP | 1 |
| Neid, M | 1 |
| Kluge, R | 1 |
| Sterker, I | 1 |
| Calabrese, F | 1 |
| Zuin, A | 1 |
| Brambilla, E | 1 |
| Zucchetta, P | 1 |
| Lunardi, F | 1 |
| Valente, M | 1 |
| Rea, F | 1 |
| Müssig, K | 1 |
| Oksüz, MO | 1 |
| Dudziak, K | 1 |
| Ueberberg, B | 1 |
| Wehrmann, M | 1 |
| Horger, M | 1 |
| Schulz, S | 1 |
| Häring, HU | 1 |
| Pfannenberg, C | 1 |
| Bares, R | 1 |
| Gallwitz, B | 1 |
| Petersenn, S | 1 |
| Srirajaskanthan, R | 1 |
| Kayani, I | 1 |
| Quigley, AM | 1 |
| Soh, J | 1 |
| Caplin, ME | 2 |
| Bomanji, J | 1 |
| Melo, IB | 1 |
| Ueda, LT | 1 |
| Araujo, EB | 1 |
| Muramoto, E | 1 |
| Barboz, MF | 1 |
| Mengatti, J | 1 |
| Buchpiguel, CA | 1 |
| Silva, CP | 1 |
| Wild, D | 1 |
| Fani, M | 1 |
| Behe, M | 2 |
| Brink, I | 1 |
| Rivier, JE | 1 |
| Reubi, JC | 3 |
| Maecke, HR | 3 |
| Weber, WA | 1 |
| Schreiter, NF | 1 |
| Brenner, W | 1 |
| Nogami, M | 1 |
| Buchert, R | 1 |
| Huppertz, A | 1 |
| Pape, UF | 1 |
| Prasad, V | 1 |
| Hamm, B | 2 |
| Maurer, MH | 1 |
| Ruf, J | 2 |
| Bomanji, JB | 1 |
| Papathanasiou, ND | 1 |
| Öberg, K | 5 |
| Boubaker, A | 1 |
| Prior, JO | 1 |
| Willi, JP | 1 |
| Champendal, M | 1 |
| Kosinski, M | 1 |
| Bischof Delaloye, A | 1 |
| Ginj, M | 1 |
| Baechler, S | 1 |
| Buchegger, F | 1 |
| Kletting, P | 1 |
| Muller, B | 1 |
| Erentok, B | 1 |
| Schmaljohann, J | 1 |
| Behrendt, FF | 1 |
| Reske, SN | 1 |
| Mottaghy, FM | 1 |
| Glatting, G | 1 |
| Dahdaleh, FS | 1 |
| Lorenzen, A | 1 |
| Rajput, M | 1 |
| Carr, JC | 1 |
| Liao, J | 1 |
| Menda, Y | 1 |
| O'Dorisio, TM | 2 |
| Howe, JR | 1 |
| Rolleman, EJ | 1 |
| Valkema, R | 8 |
| Kooij, PP | 6 |
| Hashemi, SH | 1 |
| Benjegård, SA | 1 |
| Ahlman, H | 5 |
| Wängberg, B | 4 |
| Forssell-Aronsson, E | 5 |
| Billig, H | 1 |
| Nilsson, O | 4 |
| Amthauer, H | 1 |
| Denecke, T | 1 |
| Rohlfing, T | 1 |
| Böhmig, M | 1 |
| Gutberlet, M | 1 |
| Plöckinger, U | 1 |
| Felix, R | 1 |
| Lemke, AJ | 1 |
| Orlefors, H | 1 |
| Sundin, A | 1 |
| Garske, U | 1 |
| Juhlin, C | 1 |
| Skogseid, B | 2 |
| Langstrom, B | 1 |
| Bergstrom, M | 1 |
| Eriksson, B | 3 |
| Dimitropoulos, N | 1 |
| Kontogeorgakos, D | 1 |
| Papanikolos, G | 1 |
| Koutoulidis, V | 1 |
| Hatzioannou, A | 1 |
| Mourikis, D | 1 |
| Lyra, M | 1 |
| Dimitriou, P | 1 |
| Stravaka, A | 1 |
| Vlahos, L | 1 |
| Valero, M | 1 |
| Boán, JF | 1 |
| Rodriguez-Spiteri, N | 1 |
| Torre, W | 1 |
| Richter, JA | 1 |
| Lin, YC | 1 |
| Hung, GU | 1 |
| Luo, TY | 1 |
| Chen, CH | 1 |
| Hsia, CC | 1 |
| Hen, SL | 1 |
| Ho, YJ | 1 |
| Lin, WY | 1 |
| Gotthardt, M | 1 |
| Béhé, MP | 1 |
| Grass, J | 1 |
| Bauhofer, A | 1 |
| Rinke, A | 1 |
| Schipper, ML | 1 |
| Kalinowski, M | 1 |
| Arnold, R | 1 |
| Oyen, WJ | 1 |
| Behr, TM | 1 |
| Forrer, F | 1 |
| Kwekkeboom, DJ | 11 |
| Gulec, SA | 1 |
| Baum, R | 2 |
| Barone, R | 1 |
| Walrand, S | 1 |
| Kvols, LK | 2 |
| Pauwels, S | 6 |
| Jamar, F | 5 |
| Perri, M | 1 |
| Erba, P | 1 |
| Volterrani, D | 1 |
| Lazzeri, E | 1 |
| Boni, G | 1 |
| Grosso, M | 1 |
| Mariani, G | 1 |
| Olsen, JO | 1 |
| Pozderac, RV | 1 |
| Hinkle, G | 1 |
| Hill, T | 1 |
| Schirmer, WJ | 1 |
| Ellison, EC | 1 |
| O'Dorisio, MS | 1 |
| Bajc, M | 1 |
| Ingvar, C | 1 |
| Persson, B | 1 |
| Tibblin, S | 1 |
| Karlsson, SE | 1 |
| Edenbrandt, L | 1 |
| Palmer, J | 1 |
| Fjälling, M | 3 |
| Tisell, LE | 3 |
| Oei, HY | 2 |
| de Jong, RJ | 1 |
| Dop, FJ | 1 |
| Lamberts, SW | 2 |
| Leners, N | 1 |
| Fiasse, R | 1 |
| Wiedenmann, B | 1 |
| Bäder, HM | 1 |
| Scherubl, H | 1 |
| Fett, U | 1 |
| Zimmer, T | 1 |
| Koppenhagen, K | 1 |
| Riecken, EO | 1 |
| Bakker, WH | 5 |
| van Hagen, M | 1 |
| Postema, PT | 2 |
| Kinnard, MF | 1 |
| Alavi, A | 1 |
| Rubin, RA | 1 |
| Lichtenstein, GR | 1 |
| Habbema, JD | 1 |
| Anthony, LB | 1 |
| Martin, W | 1 |
| Sandler, M | 1 |
| De Herder, WW | 4 |
| Doyle, VL | 1 |
| Payne, GS | 1 |
| Collins, DJ | 1 |
| Verrill, MW | 1 |
| Leach, MO | 1 |
| Otte, A | 1 |
| Jermann, E | 1 |
| Goetze, M | 1 |
| Bucher, HC | 1 |
| Roser, HW | 1 |
| Heppeler, A | 1 |
| Mueller-Brand, J | 1 |
| Oliaro, A | 2 |
| Filosso, PL | 2 |
| Bello, M | 2 |
| Casadio, C | 2 |
| Angusti, T | 2 |
| Masaneo, I | 2 |
| Maggi, G | 2 |
| Bisi, G | 2 |
| Kurtaran, A | 1 |
| Pfreitfellner, J | 1 |
| Schaffarich, P | 1 |
| Smith-Jones, P | 1 |
| Niederle, B | 1 |
| Raderer, M | 1 |
| Virgolini, I | 1 |
| Bergmann, H | 1 |
| Havlik, E | 1 |
| Adams, S | 1 |
| Rink, T | 1 |
| Schumm-Dräger, PM | 1 |
| Usadel, KH | 1 |
| Hör, G | 1 |
| Chiti, A | 1 |
| Spinelli, A | 1 |
| Bombardieri, E | 1 |
| Muni, A | 1 |
| Shi, W | 1 |
| Johnston, CF | 1 |
| Buchanan, KD | 1 |
| Ferguson, WR | 1 |
| Laird, JD | 1 |
| Crothers, JG | 1 |
| McIlrath, EM | 1 |
| Frilling, A | 1 |
| Malago, M | 1 |
| Martin, H | 1 |
| Broelsch, CE | 1 |
| Brice, J | 1 |
| Tiensuu Janson, E | 1 |
| Ohrvall, U | 2 |
| Nilsson, S | 1 |
| Westlin, JE | 3 |
| Schillaci, O | 1 |
| Corleto, VD | 1 |
| Annibale, B | 1 |
| Scopinaro, F | 1 |
| Delle Fave, G | 2 |
| Janson, ET | 2 |
| Kälkner, KM | 1 |
| Mielcarek, W | 1 |
| Buscombe, JR | 1 |
| Jones, AL | 1 |
| Croasdale, PL | 1 |
| Cooper, MS | 1 |
| Burroughs, AK | 1 |
| Hilson, AW | 1 |
| Tolmachev, V | 1 |
| Bernhardt, P | 1 |
| Lundqvist, H | 1 |
| Lukinius, A | 1 |
| Banzo, J | 1 |
| Abós, MD | 1 |
| Prats, E | 1 |
| García, F | 1 |
| Razola, P | 1 |
| Slooter, GD | 1 |
| Mearadji, A | 1 |
| Marquet, RL | 1 |
| Anderson, CJ | 1 |
| Dehdashti, F | 1 |
| Cutler, PD | 1 |
| Schwarz, SW | 1 |
| Laforest, R | 1 |
| Bass, LA | 1 |
| Lewis, JS | 1 |
| McCarthy, DW | 1 |
| Ichijo, T | 1 |
| Ishikawa, M | 1 |
| Shimojo, M | 1 |
| Tsubuku, M | 1 |
| Tsuboi, K | 1 |
| Miyachi, Y | 1 |
| Panzuto, F | 1 |
| Nasoni, S | 1 |
| Cascini, GL | 1 |
| Rambaldi, PF | 1 |
| Lugtenburg, PJ | 1 |
| De Jong, FH | 1 |
| Christiansen, A | 1 |
| Stridsberg, M | 1 |
| Lindemans, J | 1 |
| Ensing, G | 1 |
| Smith, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnostic Accuracy of 68Gallium Positron Emission Tomography/ Magnetic Resonance Imaging (68Ga PET/MRI), Endoscopic Ultrasound (EUS) and Computed Tomography in the Assessment of Lymph Node Metastases by Nonfunctioning Pancreatic Neuroendocrine Neoplasms[NCT03918759] | 100 participants (Actual) | Observational | 2018-11-01 | Completed | |||
| Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors[NCT02078843] | Phase 1/Phase 2 | 54 participants (Actual) | Interventional | 2014-03-31 | Terminated (stopped due to Superiority of one imaging method) | ||
| Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708] | 250 participants (Anticipated) | Interventional | 2018-07-02 | Recruiting | |||
| Phase I/II Study of Lutathera in Pediatric and Young Adult Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Express Somatostatin Type2A Receptors and Demonstrate Uptake on DOTATATE PET[NCT05278208] | Phase 1/Phase 2 | 65 participants (Anticipated) | Interventional | 2022-11-21 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for pentetic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Pe | 2019 |
68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
Topics: Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Comp | 2016 |
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Topics: Bombesin; Gallium Radioisotopes; Gastrin-Releasing Peptide; Germanium; Heterocyclic Compounds, 1-Rin | 2017 |
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neu | 2012 |
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Topics: Blood; Heterocyclic Compounds; Humans; Kidney; Liver; Neuroendocrine Tumors; Octreotide; Organometal | 2007 |
Radio-guided surgery in neuroendocrine tumors.
Topics: Gamma Cameras; Humans; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radioimmunodetection; Radio | 2007 |
Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).
Topics: Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radiation Dosage; Ra | 1995 |
Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Topics: Europe; Humans; Indium Radioisotopes; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Pancre | 1994 |
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
Topics: Humans; Indium Radioisotopes; Iodine Radioisotopes; Netherlands; Neuroendocrine Tumors; Octreotide; | 1993 |
Nuclear imaging of solid hepatic masses.
Topics: Algorithms; Carcinoma, Hepatocellular; Costs and Cost Analysis; Hemangioma, Cavernous; Humans; Indiu | 1995 |
Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
Topics: Humans; Indium Radioisotopes; Neoplasms; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radiophar | 1997 |
[The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Topics: Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pancrea | 1997 |
Somatostatin receptors and breast cancer.
Topics: Autoradiography; Breast Neoplasms; Carcinoma; Cell Differentiation; Female; Gene Expression Regulati | 1998 |
Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Topics: Female; Gastrointestinal Neoplasms; Humans; Male; Neuroendocrine Tumors; Octreotide; Pancreatic Neop | 1999 |
Peptide receptor imaging and therapy.
Topics: Humans; Indium Radioisotopes; Neoplasms; Neuroendocrine Tumors; Octreotide; Oligopeptides; Pentetic | 2000 |
[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Topics: Algorithms; Animals; Binding, Competitive; Biomarkers, Tumor; Clinical Trials, Phase I as Topic; Gas | 2000 |
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
Topics: Genetic Therapy; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Rad | 2001 |
[Medical treatment of digestive neuroendocrine tumours].
Topics: Algorithms; Antineoplastic Agents, Hormonal; Carcinoid Tumor; Cell Differentiation; Combined Modalit | 2001 |
[Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents, Hormonal; Carcinoma, Medullary; Carci | 2001 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Topics: Animals; Humans; Indium Radioisotopes; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Organomet | 2002 |
12 trials available for pentetic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
Topics: Arginine; Carcinoma, Neuroendocrine; Female; Humans; Hyperkalemia; Infusions, Intravenous; Kidney; L | 2003 |
Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
Topics: Adult; Aged; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreot | 2008 |
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Humans; Male; Middle Aged | 2008 |
Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Topics: Carcinoid Tumor; Female; Humans; Indium Radioisotopes; Intraoperative Care; Neuroendocrine Tumors; O | 1996 |
Somatostatin receptor: scintigraphy and radionuclide therapy.
Topics: Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentetic Acid | 1996 |
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Comp | 1998 |
Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
Topics: Bone Neoplasms; Humans; Liver Neoplasms; Lymphatic Metastasis; Neuroendocrine Tumors; Octreotide; Pe | 1998 |
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Topics: Animals; Humans; Indium Radioisotopes; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Pentetic | 1999 |
The role of radioactive somatostatin and its analogues in the control of tumor growth.
Topics: Cell Division; Dose-Response Relationship, Radiation; Female; Humans; Indium Radioisotopes; Neuroend | 2000 |
Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
Topics: Aged; Antineoplastic Agents; Female; Humans; Image Processing, Computer-Assisted; Indium Radioisotop | 1999 |
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours.
Topics: Adult; Aged; Bone and Bones; Carcinoid Tumor; Female; Gastrinoma; Glomerular Filtration Rate; Humans | 2000 |
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasms; Neuroendocrine Tumors; | 2002 |
46 other studies available for pentetic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Female; Humans; Immunohistochemistry; Intestinal Neoplasms; Japan; Liver; Male; Middle | 2017 |
Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?
Topics: Animals; Contrast Media; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Neuroendocrine Tumo | 2013 |
[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.
Topics: Adult; Animals; Disease Models, Animal; Female; Humans; Indium Radioisotopes; Infusions, Intra-Arter | 2014 |
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Humans; Image Processing, Computer-Assisted; Male; M | 2015 |
Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases.
Topics: Adult; Aged; Female; Humans; Liver Neoplasms; Male; Neuroendocrine Tumors; Octreotide; Pentetic Acid | 2016 |
Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
Topics: Humans; Neuroendocrine Tumors; Octreotide; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Protein Bi | 2017 |
Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Humans; Indium Radioisotopes; Male | 2008 |
Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; Graves Ophthalmopathy; Humans; Indium Radioisotope | 2008 |
Pulmonary inflammatory myofibroblastic tumour with unusual octreoscan uptake: two reports.
Topics: Adult; Female; Fibroblasts; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male | 2010 |
Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors.
Topics: Female; Humans; Immunohistochemistry; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pentetic | 2010 |
The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Humans; Male; Middle Aged; Neuroen | 2010 |
Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111In-DTPA-octreotide.
Topics: Animals; Intestines; Kidney; Ligands; Liver; Mice; Neuroendocrine Tumors; Octreotide; Pentetic Acid; | 2010 |
First clinical evidence that imaging with somatostatin receptor antagonists is feasible.
Topics: Aged; Coordination Complexes; Endocrine Gland Neoplasms; Feasibility Studies; Humans; Male; Middle A | 2011 |
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.
Topics: Adult; Aged; Cost-Benefit Analysis; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; M | 2012 |
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins.
Topics: Female; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compound | 2012 |
Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?
Topics: Endocrine Gland Neoplasms; Gallium Radioisotopes; Humans; Medical Oncology; Multimodal Imaging; Neur | 2012 |
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Oc | 2012 |
Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy.
Topics: Humans; Models, Biological; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pentetic Ac | 2012 |
The value of preoperative imaging in small bowel neuroendocrine tumors.
Topics: Aged; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Intestine, Small; Lymphatic Metast | 2013 |
111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Chelating Agents; Female; Hormones; Humans; Immunohistochemis | 2003 |
Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.
Topics: Adult; Aged; Bone Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Indium Radioisotop | 2005 |
Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.
Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Female; Humans; Male; Neuroendocrine Tumors; Pentetic Aci | 2005 |
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Topics: Adult; Aged; DNA; Female; Humans; Indium; Indium Radioisotopes; Liver; Liver Neoplasms; Magnetic Res | 2005 |
False-positive In-111 DTPA octreotide scintigraphy resulting from lung abscess in a patient with metastatic neuroendocrine pancreatic neoplasm.
Topics: Diagnosis, Differential; False Positive Reactions; Humans; Liver Neoplasms; Lung Abscess; Lung Neopl | 2006 |
A comparison of biodistribution between 111In-DTPA octreotide and 111In-DOTATOC in rats bearing pancreatic tumors.
Topics: Animals; Indium Radioisotopes; Male; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentet | 2006 |
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Glucagonoma; Humans; Indium Radioisot | 2006 |
Dynamic Octreotide scintigraphy in neuroendocrine tumours.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pentetic Acid; To | 1995 |
Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
Topics: Abdominal Neoplasms; Adult; Aged; Carcinoid Tumor; Chronic Disease; Female; Humans; Indium Radioisot | 1995 |
Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Topics: Diagnostic Imaging; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Image Enhancement; Indium | 1994 |
Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
Topics: Adult; Aged; Carcinoid Tumor; Female; Follow-Up Studies; Gamma Cameras; Gastrointestinal Neoplasms; | 1994 |
Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Oc | 1994 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
Somatostatin receptor imaging: predictive and prognostic considerations.
Topics: Carcinoid Tumor; Female; Hormone Antagonists; Humans; Hydroxyindoleacetic Acid; Indium Radioisotopes | 1996 |
Radioisotope-guided surgery in patients with neuroendocrine tumours.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreoti | 1996 |
Quantification of phosphorus metabolites in human calf muscle and soft-tissue tumours from localized MR spectra acquired using surface coils.
Topics: Adenosine Triphosphate; Gadolinium; Gadolinium DTPA; Humans; Leg; Magnetic Resonance Spectroscopy; M | 1997 |
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
Topics: Abdominal Neoplasms; Adult; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; | 1997 |
Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results.
Topics: Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Neoplasm St | 1997 |
Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.
Topics: Air Pollutants, Radioactive; Ambulatory Care; Environmental Exposure; Family; Humans; Indium Radiois | 1997 |
[Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Topics: Carcinoma; Humans; Indium Radioisotopes; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Pentetic | 1997 |
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Child; Female; Humans; Indium Radioi | 1998 |
First peptide agent enters clinical arena.
Topics: Drug Approval; Humans; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Sensi | 1994 |
Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors--evaluation of therapeutic and toxic effects.
Topics: Aged; Dose-Response Relationship, Radiation; Female; Humans; Indium Radioisotopes; Male; Middle Aged | 1999 |
114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-phe-octreotide.
Topics: Animals; Cadmium Radioisotopes; Cyclotrons; Indium Radioisotopes; Isotope Labeling; Mice; Mice, Nude | 2000 |
Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
Topics: Adult; Aged; Autoradiography; Carcinoid Tumor; Cell Membrane; Cell Nucleus; Cytoplasm; Female; Human | 2000 |
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Topics: Adenoma, Islet Cell; Aged; Animals; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Ind | 2001 |
Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors.
Topics: Adult; Aged; Diagnosis, Differential; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Male | 2001 |